IPSEN overview

Aggregated presentation by day and by market Statement of transactions in own shares from June 23rd to June 27th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150 335 100,58955 AQEU IPSEN 549300M6SGDPB4Z94P11 23/06/2025 FR0010259150 800 100,649...

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers ) Market: Euronext Paris ISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 31 May 2025 83,814,526 Gross total* of voting rights: 132,084,744 Net...

Regulated information Ipsen initiates a share buy-back program to cover its free employee share-allocation plan PARIS, FRANCE, 2 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has appointed an investment-services provider to purchase an aggregate number of Ipsen S.A. shares up to 600,000, or about 0.72% of the share capital, over a maximum period of six months. The shares purchased under this agreement will be allocated mainly to cover Ipsen’s free employee...

PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy & Transformation, effective May 14, 2025. She will serve on the Executive Leadership Team and report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “We are very pleased to welcome Laura to Ipsen as our EVP for Strategy & Transformation. I have observed Laura’s involvement in...

Information relating to the holding of the Combined Shareholders’ Meeting of 21 May 2025 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 30 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Shareholders of the Company are invited to participate in the Combined Shareholders’ Meeting of Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Wednesday 21 May 2025 at 3:00 p.m. (Paris time) at the Salons de l'Hôtel...

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers ) Market: Euronext Paris ISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 31 March 2025 83,814,526 Gross total* of voting rights: 131,926,652 Net...

Ipsen publishes its 2024 Universal Registration Document PARIS, FRANCE, 8 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the filing of its 2024 Universal Registration Document with the French Autorité des Marchés Financiers (AMF) on 7 April 2025 and registered under the number D.25-0232. The document is available on ipsen.com and amf-france.org . Copies will also be available at Ipsen’s headquarters – 70 rue Balard, 75015 Paris, France. The Universal Registration Document...

Ipsen S.A. - 2024 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2024_EN...